Characterization and genome analysis of a novel phage BP15 infecting Vibrio parahaemolyticus
This study aimed to isolate and characterize phages for their application in lysing Vibrio parahaemolyticus. A novel phage, vB_VpaS_BP15 (BP15), was found to be highly effective against BCRC12959 at MOIs ranging from 0.01 to 10. Despite a low multiplicity of infection (MOI) of 0.001, BP15 caused growth retention. The findings highlight the potential of phage BP15 as a biocontrol agent against Vibrio parahaemolyticus in Taiwan.
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Bangalore Bioinnovation Centre |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
 |
BD |
AMR NEWS
Your Biweekly Source for Global AMR Insights!
Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.
Don’t miss out on staying ahead in the global AMR movement—subscribe now!